Share Email Print

Proceedings Paper

Optical thromboelastography (OTEG) for diagnosis of hyperfibrinolysis in patients (Conference Presentation)
Author(s): Markandey M. Tripathi; Diane M. Tshikudi; Seemantini K. Nadkarni
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Fibrinolysis is a process that regulates the breakdown of a blood clot to enable wound healing and is an essential component of hemostasis. Abnormalities in the fibrinolysis pathway may cause hyperfibrinolysis, associated with the increased risk of life-threatening bleeding particularly following acute trauma or major surgery. Assessing fibrinolytic activity in bleeding patients at the bedside can enable the timely administration of fibrinolysis inhibitors to improve prognosis. Optical thromboelastography (OTEG), a novel technique to assess blood coagulation status, has the potential to quantify fibrinolysis in real-time at PoC. The goal of the current study is to test the accuracy of OTEG in quantifying fibrinolytic status of human blood. Fibrinolysis is activated by adding varying concentrations of tissue plasminogen activator (tPA), a known fibrinolysis activator. The blood sample is illuminated by laser light and the resultant speckle intensity autocorrelation curve is used to derive changes in clot viscoelastic modulus during coagulation. From the OTEG trace, the coagulation parameters, clotting time (R), clot progression time (K), maximum clot strength (MA), and clot lysis (LY%) are derived. Our results indicate that increased tPA (0-0.5μM/ml) activation causes dose-dependent increase in LY% measured with OTEG: For instance, the addition of 0.5μM/ml of tPA increased LY% from 14.0 % to 81.5%. OTEG measurements also show a strong correlation with standard-reference mechanical Thromboelastography (TEG) measurements (N = 15, R=0.87, p<0.05). These results demonstrate that OTEG can accurately evaluate fibrinolysis and may provide the capability for identifying hyperfibrinolytic patients at an increased risk of life-threatening hemorrhage.

Paper Details

Date Published: 27 April 2016
PDF: 1 pages
Proc. SPIE 9715, Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics, 971504 (27 April 2016); doi: 10.1117/12.2213074
Show Author Affiliations
Markandey M. Tripathi, Wellman Ctr. for Photomedicine (United States)
Harvard Medical School (United States)
Diane M. Tshikudi, Wellman Ctr. for Photomedicine (United States)
Seemantini K. Nadkarni, Wellman Ctr. for Photomedicine (United States)

Published in SPIE Proceedings Vol. 9715:
Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics
Gerard L. Coté, Editor(s)

© SPIE. Terms of Use
Back to Top